SBI Securities’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$251K Sell
1,325
-38
-3% -$5.64K 0.01% 607
2026
Q1
$127K Sell
1,363
-234
-15% -$20.7K ﹤0.01% 772
2025
Q4
$128K Buy
1,597
+1,399
+707% +$117K ﹤0.01% 762
2025
Q3
$19.3K Buy
198
+28
+16% +$2.25K ﹤0.01% 1465
2025
Q2
$11.8K Buy
170
+48
+39% +$2.74K ﹤0.01% 1634
2025
Q1
$6.06K Sell
122
-69
-36% -$4.36K ﹤0.01% 1819
2024
Q4
$13.3K Buy
+191
New +$15.9K ﹤0.01% 1520

Other funds holding ACLS

SBI Securities's ACLS Position: Q2 2026 in Review

SBI Securities reduced its Axcelis (ACLS) stake by 2.8% in Q2 2026, selling an estimated $5.64K and leaving 1,325 shares worth $251K. The position accounts for 0.01% of the portfolio, ranked #607.

SBI Securities first reported a position in ACLS in Q4 2024 and has held it in 7 quarters since. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • SBI Securities held 1,325 shares of Axcelis worth $251K as of Q2 2026.
  • SBI Securities sold 38 Axcelis shares in Q2 2026, an estimated $5.64K.
  • Axcelis made up 0.01% of SBI Securities's portfolio in Q2 2026, its #607 holding.
  • SBI Securities first reported a position in Axcelis in Q4 2024 and has held it in 7 quarters since.
  • 441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.